The impact of type and timing of radiation therapy (RT) relative to ipilimumab on survival in metastatic melanoma patients.

Rahul Gupta,Christopher Johnson,E.M. Suarez,Keisuke Shirai

Journal of Clinical Oncology（2016）

引用 0|浏览0

暂无评分

摘要

e21013Background: Stage IV melanoma patients treated with ipilimumab (Ipi) have a median survival of 40 to 44 weeks (wks). Recent studies have demonstrated the combination of RT and Ipi can improve...

查看译文

关键词

metastatic melanoma patients,radiation therapy,ipilimumab

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要